Renaissance Technologies's ABVC Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 110.5K shares of ABVC BioPharma, Inc. (ABVC) worth $335,920, representing 0.00% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, Renaissance Technologies has maintained this position in ABVC for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 68.8K shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's ABVC BioPharma (ABVC) Holding Value Over Time
Track share changes against reported price movement
Quarterly ABVC BioPharma (ABVC) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2023 | +36,100 | New Buy | 36,100 | $1.16 |
| Q1 2024 | -36,100 | Sold Out | 36,100 | $0.00 |
| Q2 2025 | +41,706 | New Buy | 41,706 | $2.23 |
| Q3 2025 | +68,794 | Add 164.95% | 110,500 | $3.04 |
Renaissance Technologies's ABVC BioPharma Investment FAQs
Renaissance Technologies first purchased ABVC BioPharma, Inc. (ABVC) in Q4 2023, acquiring 36,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held ABVC BioPharma, Inc. (ABVC) for 8 quarters since Q4 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to ABVC BioPharma, Inc. (ABVC) was in Q3 2025, adding 110,500 shares worth $335,920. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 110,500 shares of ABVC BioPharma, Inc. (ABVC), valued at approximately $335,920. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ABVC BioPharma, Inc. (ABVC) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in ABVC BioPharma, Inc. (ABVC) was 110,500 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.